Literature DB >> 8288057

Effect of NIDDM on the kinetics of whole-body protein metabolism.

R Gougeon1, P B Pencharz, E B Marliss.   

Abstract

We postulated that dietary protein utilization and body protein metabolism are altered in hyperglycemic individuals with non-insulin-dependent diabetes mellitus (NIDDM). This was tested by estimating the kinetics of protein metabolism in obese NIDDM patients in the hyperglycemic state of isoenergetic feeding and in the normoglycemic state induced by the prolonged use of a very-low-energy diet (VLED) and comparing them with results in obese nondiabetic subjects studied previously. Seven obese subjects with NIDDM (one male, six females, body mass index = 35.8 +/- 2.0 kg/m2) were given a 1.7 MJ (410 kcal) all protein (93 g/day) diet derived from hydrolyzed collagen and supplemented with tryptophan and methionine, which provides 16% of its amino acids as essential, a multivitamin and mineral supplement, and 16 mmol KCl for 42 days. During the seven-day isoenergetic diet and at weeks 4 and 6 of the VLED, amino nitrogen (N) flux rate was calculated from the urine [15N]urea enrichment by using the 60-h oral [15N]glycine method to obtain the integrated feeding-fasting metabolism. Rates of synthesis (S) and breakdown (B) were calculated from N flux. At day 7 of the isoenergetic diet, whole-body N flux, S, B, and resting metabolic rate (RMR) were 12-24% greater (P < 0.05) in the NIDDM subjects than observed in nondiabetic obese subjects. Mean plasma glucose decreased (P < 0.05) from the isoenergetic period (14.9 +/- 2.4 mM) to 7.2 +/- 1.2 mM at week 4 and 6.5 +/- 1.1 mM at week 6 of the VLED. RMR declined progressively by 25% at week 5 of the VLED. Corresponding significant (P < 0.05) decreases from isoenergetic feeding to weeks 4 and 6 of the VLED occurred in whole-body N flux (from 51 +/- 2 to 42 +/- 1 g N/day), in S (from 38 +/- 3 to 24 +/- 1 g N/day), and in B (from 39 +/- 3 to 26 +/- 1 g N/day) resulting in net losses (S-B). S-B was significantly more negative (P < 0.05) in NIDDM than in the nondiabetic obese subjects at week 4 (-1.5 +/- 0.5 vs. 0.9 +/- 0.3 g N/day) but not at week 6 (-1.3 +/- 0.4 vs. -0.9 +/- 4 g N/day). During the VLED, N balance became less negative with time but never reached equilibrium in NIDDM. Thus, abnormal protein metabolism is present in NIDDM in the isoenergetic fed state with moderate hyperglycemia and persists during a VLED that restores glycemia to near normal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288057     DOI: 10.2337/diab.43.2.318

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin.

Authors:  M Heishi; J Ichihara; R Teramoto; Y Itakura; K Hayashi; H Ishikawa; H Gomi; J Sakai; M Kanaoka; M Taiji; T Kimura
Journal:  Diabetologia       Date:  2006-05-23       Impact factor: 10.122

2.  Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes.

Authors:  Jill A Bell; Elena Volpi; Satoshi Fujita; Jerson G Cadenas; Melinda Sheffield-Moore; Blake B Rasmussen
Journal:  J Nutr       Date:  2006-05       Impact factor: 4.798

3.  Acute estradiol treatment reduces skeletal muscle protein breakdown markers in early- but not late-postmenopausal women.

Authors:  Young-Min Park; Amy C Keller; Shauna S Runchey; Benjamin F Miller; Wendy M Kohrt; Rachael E Van Pelt; Chounghun Kang; Catherine M Jankowski; Kerrie L Moreau
Journal:  Steroids       Date:  2019-03-27       Impact factor: 2.668

4.  Exercise in ZDF rats does not attenuate weight gain, but prevents hyperglycemia concurrent with modulation of amino acid metabolism and AKT/mTOR activation in skeletal muscle.

Authors:  Olasunkanmi A J Adegoke; Holly E Bates; Michael A Kiraly; Mladen Vranic; Michael C Riddell; Errol B Marliss
Journal:  Eur J Nutr       Date:  2014-08-13       Impact factor: 5.614

5.  Beneficial role of amino acids in mitigating cytoskeletal actin glycation and improving F-actin content: in vitro.

Authors:  K N Sulochana; C Indra; M Rajesh; V Srinivasan; S Ramakrishnan
Journal:  Glycoconj J       Date:  2001-04       Impact factor: 2.916

Review 6.  Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.

Authors:  Sean H Adams
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

7.  Effects of type 2 diabetes and insulin on whole-body, splanchnic, and leg protein metabolism.

Authors:  Kevin R Short; Brian A Irving; Ananda Basu; C Michael Johnson; K Sreekumaran Nair; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2012-10-02       Impact factor: 5.958

Review 8.  Protein and diabetes: much advice, little research.

Authors:  Marion J Franz
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

9.  Beneficial effects of flaxseed oil and fish oil diet are through modulation of different hepatic genes involved in lipid metabolism in streptozotocin-nicotinamide induced diabetic rats.

Authors:  Prasad P Devarshi; Nivedita M Jangale; Arvindkumar E Ghule; Subhash L Bodhankar; Abhay M Harsulkar
Journal:  Genes Nutr       Date:  2012-12-07       Impact factor: 5.523

Review 10.  Adiponectin signaling in the liver.

Authors:  Terry P Combs; Errol B Marliss
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.